• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

难治性Lennox-Gastaut综合征:治疗趋势、挑战及未来方向

Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.

作者信息

Ostendorf Adam P, Ng Yu-Tze

机构信息

Department of Pediatrics, Neurology Section, Nationwide Children's Hospital, The Ohio State University, Columbus, OH.

Department of Pediatrics, Baylor College of Medicine, The Children's Hospital of San Antonio, San Antonio, TX, USA.

出版信息

Neuropsychiatr Dis Treat. 2017 Apr 20;13:1131-1140. doi: 10.2147/NDT.S115996. eCollection 2017.

DOI:10.2147/NDT.S115996
PMID:28461749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5404809/
Abstract

Lennox-Gastaut syndrome is a severe, childhood-onset electroclinical syndrome comprised of multiple seizure types, intellectual and behavioral disturbances and characteristic findings on electroencephalogram of slow spike and wave complexes and paroxysmal fast frequency activity. Profound morbidity often accompanies a common and severe seizure type, the drop attack. Seizures often remain refractory, or initial treatment efficacy fades. Few individuals are seizure free despite the development of multiple generations of antiseizure medications over decades and high-level evidence on several choices. Approved medications such as lamotrigine, topiramate, rufinamide, felbamate and clobazam have demonstrated efficacy in reducing seizure burden. Cannabidiol has emerged as a promising investigational therapy with vast social interest yet lacks a standard, approved formulation. Palliative surgical procedures, such as vagal nerve stimulation and corpus callosotomy may provide reduction in total seizures and drop attacks. Emerging evidence suggests that complete callosotomy provides greater improvement in seizures without additional side effects. Etiologies such as dysplasia or hypothalamic hamartoma may be amenable for focal resection and thus offer potential to reverse this devastating epileptic encephalopathy.

摘要

伦诺克斯-加斯托综合征是一种严重的儿童期起病的电临床综合征,由多种发作类型、智力和行为障碍以及脑电图上慢棘慢复合波和阵发性快频率活动的特征性表现组成。严重的发病率常伴随着一种常见且严重的发作类型——跌倒发作。癫痫发作往往难以控制,或者初始治疗效果逐渐消失。尽管数十年来开发了多代抗癫痫药物,并且有几种选择的高级别证据,但很少有人能无癫痫发作。已批准的药物,如拉莫三嗪、托吡酯、卢非酰胺、非氨酯和氯巴占,已证明在减轻癫痫发作负担方面有效。大麻二酚已成为一种有前景的研究性疗法,引起了广泛的社会关注,但缺乏标准的、已批准的制剂。姑息性手术,如迷走神经刺激术和胼胝体切开术,可能会减少癫痫发作总数和跌倒发作。新出现的证据表明,完全胼胝体切开术能在不产生额外副作用的情况下,使癫痫发作得到更大改善。发育异常或下丘脑错构瘤等病因可能适合进行病灶切除,从而有可能逆转这种毁灭性的癫痫性脑病。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/b7337579a4d9/ndt-13-1131Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ebffa23149c7/ndt-13-1131Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/f30fac12ecc4/ndt-13-1131Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ba95f4f7eed1/ndt-13-1131Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ca83833ee190/ndt-13-1131Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/97a0fa9a20c9/ndt-13-1131Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/b7337579a4d9/ndt-13-1131Fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ebffa23149c7/ndt-13-1131Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/f30fac12ecc4/ndt-13-1131Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ba95f4f7eed1/ndt-13-1131Fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/ca83833ee190/ndt-13-1131Fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/97a0fa9a20c9/ndt-13-1131Fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a5b1/5404809/b7337579a4d9/ndt-13-1131Fig6.jpg

相似文献

1
Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions.难治性Lennox-Gastaut综合征:治疗趋势、挑战及未来方向
Neuropsychiatr Dis Treat. 2017 Apr 20;13:1131-1140. doi: 10.2147/NDT.S115996. eCollection 2017.
2
Anti-seizure medications for Lennox-Gastaut syndrome.用于 Lennox-Gastaut 综合征的抗癫痫药物。
Cochrane Database Syst Rev. 2021 Apr 7;4(4):CD003277. doi: 10.1002/14651858.CD003277.pub4.
3
Current and emerging pharmacotherapy for the treatment of Lennox-Gastaut syndrome.用于治疗伦诺克斯-加斯东综合征的现有及新兴药物疗法。
Expert Opin Pharmacother. 2023 May-Aug;24(11):1249-1268. doi: 10.1080/14656566.2023.2215924. Epub 2023 Jun 5.
4
Lennox-Gastaut syndrome: a comprehensive review.朗格汉斯细胞组织细胞增生症:全面综述。
Neurol Sci. 2018 Mar;39(3):403-414. doi: 10.1007/s10072-017-3188-y. Epub 2017 Nov 9.
5
Management of seizures in Lennox-Gastaut syndrome.Lennox-Gastaut 综合征的癫痫发作管理。
Paediatr Drugs. 2011 Apr 1;13(2):107-18. doi: 10.2165/11536940-000000000-00000.
6
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.拓展 Lennox-Gastaut 综合征的治疗领域:现有及未来策略。
CNS Drugs. 2021 Jan;35(1):61-83. doi: 10.1007/s40263-020-00784-8. Epub 2021 Jan 21.
7
The pharmacological management of Lennox-Gastaut syndrome and critical literature review.Lennox-Gastaut 综合征的药物治疗及关键文献复习。
Seizure. 2018 Dec;63:17-25. doi: 10.1016/j.seizure.2018.10.016. Epub 2018 Oct 26.
8
Expert opinion: Proposed diagnostic and treatment algorithms for Lennox-Gastaut syndrome in adult patients.专家意见:成人 Lennox-Gastaut 综合征的诊断和治疗建议。
Epilepsy Behav. 2020 Sep;110:107146. doi: 10.1016/j.yebeh.2020.107146. Epub 2020 Jun 18.
9
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.Lennox-Gastaut 综合征相关癫痫患儿中使用大麻二酚治疗的随机、双盲、安慰剂对照 3 期临床试验(GWPCARE4)
Lancet. 2018 Mar 17;391(10125):1085-1096. doi: 10.1016/S0140-6736(18)30136-3. Epub 2018 Jan 26.
10
Don't Fear the Reefer-Evidence Mounts for Plant-Based Cannabidiol as Treatment for Epilepsy.别怕大麻二酚——植物性大麻二酚作为癫痫治疗手段的证据不断增加。
Epilepsy Curr. 2019 Mar-Apr;19(2):93-95. doi: 10.1177/1535759719835671.

引用本文的文献

1
Clinically Meaningful Reduction in Drop Seizures in Patients with Lennox-Gastaut Syndrome Treated with Cannabidiol: Post Hoc Analysis of Phase 3 Clinical Trials.接受大麻二酚治疗的伦诺克斯-加斯托综合征患者癫痫发作次数的临床显著减少:3期临床试验的事后分析
CNS Drugs. 2025 Aug 7. doi: 10.1007/s40263-025-01201-8.
2
Clinical features and underlying etiology of children with Lennox-Gastaut syndrome.儿童 Lennox-Gastaut 综合征的临床特征和潜在病因。
J Neurol. 2024 Aug;271(8):5392-5401. doi: 10.1007/s00415-024-12465-3. Epub 2024 Jul 15.
3
GABA Receptor β3 Subunit Mutation N328D Heterozygous Knock-in Mice Have Lennox-Gastaut Syndrome.

本文引用的文献

1
Low-dose fenfluramine significantly reduces seizure frequency in Dravet syndrome: a prospective study of a new cohort of patients.低剂量芬氟拉明显著降低德雷维特综合征的癫痫发作频率:一项对新患者队列的前瞻性研究。
Eur J Neurol. 2017 Feb;24(2):309-314. doi: 10.1111/ene.13195. Epub 2016 Oct 28.
2
Resective surgery combined with corpus callosotomy for children with non-focal lesional Lennox-Gastaut syndrome.切除性手术联合胼胝体切开术治疗非局灶性病变的儿童Lennox-Gastaut综合征。
Acta Neurochir (Wien). 2016 Nov;158(11):2177-2184. doi: 10.1007/s00701-016-2947-5. Epub 2016 Sep 15.
3
Transcranial Direct Current Stimulation for Treatment of Childhood Pharmacoresistant Lennox-Gastaut Syndrome: A Pilot Study.
GABA 受体 β3 亚单位突变 N328D 杂合敲入小鼠具有 Lennox-Gastaut 综合征。
Int J Mol Sci. 2023 May 8;24(9):8458. doi: 10.3390/ijms24098458.
4
Rufinamide, a Triazole-Derived Antiepileptic Drug, Stimulates Ca-Activated K Currents While Inhibiting Voltage-Gated Na Currents.鲁非尼酰胺,一种三氮唑衍生的抗癫痫药物,在抑制电压门控钠电流的同时刺激钙激活钾电流。
Int J Mol Sci. 2022 Nov 8;23(22):13677. doi: 10.3390/ijms232213677.
5
Association Between Characteristics of National Association of Epilepsy Centers and Reported Utilization of Specific Surgical Techniques.国家癫痫中心特征与特定手术技术应用报告之间的关联。
Neurology. 2023 Feb 14;100(7):e719-e727. doi: 10.1212/WNL.0000000000201526. Epub 2022 Nov 2.
6
A phase 2, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of soticlestat as adjunctive therapy in pediatric patients with Dravet syndrome or Lennox-Gastaut syndrome (ELEKTRA).一项评估索替司他作为辅助治疗用于 Dravet 综合征或 Lennox-Gastaut 综合征(ELEKTRA)儿科患者的疗效和安全性的 2 期、随机、双盲、安慰剂对照研究。
Epilepsia. 2022 Oct;63(10):2671-2683. doi: 10.1111/epi.17367. Epub 2022 Aug 4.
7
Time to onset of cannabidiol (CBD) treatment effect in Lennox-Gastaut syndrome: Analysis from two randomized controlled trials.Lennox-Gastaut 综合征中大麻二酚(CBD)治疗效果出现时间:两项随机对照试验分析。
Epilepsia. 2021 May;62(5):1130-1140. doi: 10.1111/epi.16878. Epub 2021 Apr 2.
8
Expanding the Treatment Landscape for Lennox-Gastaut Syndrome: Current and Future Strategies.拓展 Lennox-Gastaut 综合征的治疗领域:现有及未来策略。
CNS Drugs. 2021 Jan;35(1):61-83. doi: 10.1007/s40263-020-00784-8. Epub 2021 Jan 21.
9
Novel seizure outcomes in patients with Lennox-Gastaut syndrome: Post hoc analysis of seizure-free days in rufinamide Study 303.Lennox-Gastaut综合征患者的新型癫痫发作结局:鲁非酰胺研究303中无癫痫发作天数的事后分析。
Epilepsia Open. 2019 Mar 13;4(2):275-280. doi: 10.1002/epi4.12314. eCollection 2019 Jun.
10
Drug refractory epilepsy in children: many concerns!儿童药物难治性癫痫:诸多担忧!
Childs Nerv Syst. 2019 Jul;35(7):1103-1105. doi: 10.1007/s00381-019-04154-8. Epub 2019 May 6.
经颅直流电刺激治疗儿童药物难治性伦诺克斯-加斯东综合征:一项初步研究。
Front Neurol. 2016 May 4;7:66. doi: 10.3389/fneur.2016.00066. eCollection 2016.
4
Combined surgical intervention with vagus nerve stimulation following corpus callosotomy in patients with Lennox-Gastaut syndrome.对于患有伦诺克斯-加斯托综合征的患者,在胼胝体切开术后联合迷走神经刺激进行手术干预。
Acta Neurochir (Wien). 2016 May;158(5):1005-12. doi: 10.1007/s00701-016-2765-9. Epub 2016 Mar 15.
5
Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study.鲁非酰胺在年龄小于4岁的Lennox-Gastaut综合征儿科患者中的安全性和药代动力学特征:一项多中心、随机、活性对照、开放标签研究的中期分析。
Eur J Paediatr Neurol. 2016 May;20(3):393-402. doi: 10.1016/j.ejpn.2015.12.015. Epub 2016 Jan 11.
6
Who to target in sudden unexpected death in epilepsy prevention and how? Risk factors, biomarkers, and intervention study designs.在癫痫预防中的意外猝死预防应针对哪些人群以及如何预防?风险因素、生物标志物及干预研究设计。
Epilepsia. 2016 Jan;57 Suppl 1:4-16. doi: 10.1111/epi.13234.
7
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.大麻二酚治疗耐药性癫痫患者:一项开放标签的干预性试验。
Lancet Neurol. 2016 Mar;15(3):270-8. doi: 10.1016/S1474-4422(15)00379-8. Epub 2015 Dec 24.
8
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.氯巴占与大麻二酚在难治性癫痫儿童中的药物相互作用。
Epilepsia. 2015 Aug;56(8):1246-51. doi: 10.1111/epi.13060. Epub 2015 Jun 26.
9
Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome.富含大麻二酚的大麻提取物治疗小儿癫痫的感知疗效:对婴儿痉挛症和伦诺克斯-加斯托综合征的潜在作用。
Epilepsy Behav. 2015 Jun;47:138-41. doi: 10.1016/j.yebeh.2015.04.009. Epub 2015 Apr 29.
10
Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy.家长对口服大麻提取物治疗难治性癫痫疗效的报告。
Epilepsy Behav. 2015 Apr;45:49-52. doi: 10.1016/j.yebeh.2015.02.043. Epub 2015 Apr 3.